Curaleaf Holdings Key Fundamental Indicators
| CURLF Stock | USD 2.37 0.05 2.07% |
As of the 17th of February 2026, Curaleaf Holdings shows the Risk Adjusted Performance of 0.0149, downside deviation of 7.91, and Mean Deviation of 5.26. Curaleaf Holdings technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down and interpolate nineteen technical drivers for Curaleaf Holdings, which can be compared to its peers. Please confirm Curaleaf Holdings treynor ratio, as well as the relationship between the downside variance and kurtosis to decide if Curaleaf Holdings is priced correctly, providing market reflects its regular price of 2.37 per share. Please also double-check Curaleaf Holdings total risk alpha, which is currently at (0.41) to validate the company can sustain itself at a future point.
Curaleaf Holdings' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Curaleaf Holdings' valuation are provided below:Curaleaf Holdings does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Curaleaf |
Curaleaf Holdings 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Curaleaf Holdings' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Curaleaf Holdings.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in Curaleaf Holdings on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Curaleaf Holdings or generate 0.0% return on investment in Curaleaf Holdings over 90 days. Curaleaf Holdings is related to or competes with Sihuan Pharmaceutical, Dermapharm Holding, Almirall, CanSino Biologics, Trulieve Cannabis, HUTCHMED (China), and Fagron NV. Curaleaf Holdings, Inc. operates a cannabis operator in the United States More
Curaleaf Holdings Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Curaleaf Holdings' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Curaleaf Holdings upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 7.91 | |||
| Information Ratio | 0.0011 | |||
| Maximum Drawdown | 69.91 | |||
| Value At Risk | (7.95) | |||
| Potential Upside | 9.23 |
Curaleaf Holdings Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Curaleaf Holdings' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Curaleaf Holdings' standard deviation. In reality, there are many statistical measures that can use Curaleaf Holdings historical prices to predict the future Curaleaf Holdings' volatility.| Risk Adjusted Performance | 0.0149 | |||
| Jensen Alpha | 0.0501 | |||
| Total Risk Alpha | (0.41) | |||
| Sortino Ratio | 0.0012 | |||
| Treynor Ratio | 1.02 |
Curaleaf Holdings February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0149 | |||
| Market Risk Adjusted Performance | 1.03 | |||
| Mean Deviation | 5.26 | |||
| Semi Deviation | 7.57 | |||
| Downside Deviation | 7.91 | |||
| Coefficient Of Variation | 13657.32 | |||
| Standard Deviation | 8.51 | |||
| Variance | 72.49 | |||
| Information Ratio | 0.0011 | |||
| Jensen Alpha | 0.0501 | |||
| Total Risk Alpha | (0.41) | |||
| Sortino Ratio | 0.0012 | |||
| Treynor Ratio | 1.02 | |||
| Maximum Drawdown | 69.91 | |||
| Value At Risk | (7.95) | |||
| Potential Upside | 9.23 | |||
| Downside Variance | 62.51 | |||
| Semi Variance | 57.23 | |||
| Expected Short fall | (6.05) | |||
| Skewness | 0.641 | |||
| Kurtosis | 8.47 |
Curaleaf Holdings Backtested Returns
Curaleaf Holdings appears to be dangerous, given 3 months investment horizon. Curaleaf Holdings secures Sharpe Ratio (or Efficiency) of 0.0831, which signifies that the company had a 0.0831 % return per unit of risk over the last 3 months. By analyzing Curaleaf Holdings' technical indicators, you can evaluate if the expected return of 0.69% is justified by implied risk. Please makes use of Curaleaf Holdings' Risk Adjusted Performance of 0.0149, mean deviation of 5.26, and Downside Deviation of 7.91 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Curaleaf Holdings holds a performance score of 6. The firm shows a Beta (market volatility) of 0.0511, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Curaleaf Holdings' returns are expected to increase less than the market. However, during the bear market, the loss of holding Curaleaf Holdings is expected to be smaller as well. Please check Curaleaf Holdings' downside variance, and the relationship between the treynor ratio and kurtosis , to make a quick decision on whether Curaleaf Holdings' price patterns will revert.
Auto-correlation | -0.66 |
Very good reverse predictability
Curaleaf Holdings has very good reverse predictability. Overlapping area represents the amount of predictability between Curaleaf Holdings time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Curaleaf Holdings price movement. The serial correlation of -0.66 indicates that around 66.0% of current Curaleaf Holdings price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.66 | |
| Spearman Rank Test | -0.32 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Curaleaf Holdings has an Operating Margin of 0.0926%. This is 100.26% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The operating margin for all United States stocks is 101.68% lower than that of the firm.
Curaleaf Holdings Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Curaleaf Holdings's current stock value. Our valuation model uses many indicators to compare Curaleaf Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Curaleaf Holdings competition to find correlations between indicators driving Curaleaf Holdings's intrinsic value. More Info.Curaleaf Holdings is rated below average in return on equity category among its peers. It is rated fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Curaleaf Holdings' earnings, one of the primary drivers of an investment's value.Curaleaf Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Curaleaf Holdings' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Curaleaf Holdings could also be used in its relative valuation, which is a method of valuing Curaleaf Holdings by comparing valuation metrics of similar companies.Curaleaf Holdings is currently under evaluation in operating margin category among its peers.
Curaleaf Fundamentals
| Return On Equity | -0.0776 | |||
| Return On Asset | 0.0226 | |||
| Profit Margin | (0.1) % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 4.72 B | |||
| Shares Outstanding | 623.38 M | |||
| Shares Owned By Insiders | 32.36 % | |||
| Shares Owned By Institutions | 0.30 % | |||
| Price To Book | 2.36 X | |||
| Price To Sales | 2.56 X | |||
| Revenue | 1.21 B | |||
| Gross Profit | 687.59 M | |||
| EBITDA | 287.7 M | |||
| Net Income | (101.73 M) | |||
| Cash And Equivalents | 187.12 M | |||
| Cash Per Share | 0.26 X | |||
| Total Debt | 434.12 M | |||
| Debt To Equity | 0.56 % | |||
| Current Ratio | 2.44 X | |||
| Book Value Per Share | 2.32 X | |||
| Cash Flow From Operations | (33.96 M) | |||
| Earnings Per Share | (0.15) X | |||
| Price To Earnings To Growth | (2.23) X | |||
| Target Price | 7.98 | |||
| Number Of Employees | 5.6 K | |||
| Beta | 1.78 | |||
| Market Capitalization | 2.65 B | |||
| Total Asset | 3.26 B | |||
| Z Score | 3.6 | |||
| Net Asset | 3.26 B |
About Curaleaf Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Curaleaf Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Curaleaf Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Curaleaf Holdings based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Curaleaf Holdings, Inc. operates a cannabis operator in the United States. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts. Curaleaf Holdings operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 5600 people.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Curaleaf OTC Stock
Curaleaf Holdings financial ratios help investors to determine whether Curaleaf OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Curaleaf with respect to the benefits of owning Curaleaf Holdings security.